article thumbnail

Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death

Xconomy

That’s according to a new study from University of California, Berkeley data scientists who analyzed the records of more than 400,000 people in the United Kingdom.

Study 78
article thumbnail

Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects

Xconomy

A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche was suspended after two reports of infections related to a device used to take samples of cerebral spinal fluid during the trial.

Sample 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

Xconomy

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today. The VA is running its own long-term study with nearly half a million participants so far.).

Study 59
article thumbnail

Cancer Wrap: Blueprint, Checkmate, More AACR News & Phase 3 Blues

Xconomy

There were results from earlier stages of clinical studies and preclinical research, which is the traditional material for AACR, as well as a couple of late-stage letdowns that came to light. Here’s a sample of other cancer news blowing in the Windy City and beyond this week.

News 65
article thumbnail

Organovo to Test Pre-Clinical Drugs on Bio-Printed Kidney Tissue

Xconomy

It’s been almost two years since Organovo (NYSE: ONVO ) created a new business—using its bio-printing technology to create 3-D samples of living human liver tissue for use in testing the toxicity of pre-clinical drug candidates. The company said it has signed multiple commercial orders for its kidney drug-testing service.

Sample 40
article thumbnail

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

Xconomy

Organovo unveiled its plans to develop “therapeutic” tissue after showing in preclinical animal studies that bio-printed liver patches successfully grafted, formed blood vessels, and functioned normally, according to a statement today. liver transplant waiting list. Such capabilities, though, remain years and perhaps even decades away.

San Diego 105
article thumbnail

Crowdfunding an HIV Vaccine: Dr. Rubsamen of Immunity Project

Tech Zulu Event

Since the official YC announcement and launch of their crowdfunding campaign, they’ve successfully raised an initial goal of $482,000; to fund a final immunization experiments before undergoing Phase I clinical studies. Extra : They’ve also added the Immunity Project blog , where you can follow closely on progress made!